company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,32043000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,74669000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6940000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6570000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,120322000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5040000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,9335000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,381000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13344000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,,totalassets,Total Assets,=,debit,usd,138706000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2745000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14113000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentliabilities,dividendspayable,Dividends Payable,+,credit,usd,261000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9553000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,26672000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,78949000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,343000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,79292000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,105621000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,426940000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-394149000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-49000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,32742000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,32742000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,32742000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,,2012-06-30,2012-08-14 11:41:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,138706000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27909000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,58759000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6054000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,11259000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,104081000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4834000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,9255000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1055000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,381000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14296000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,,totalassets,Total Assets,=,debit,usd,123211000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,771000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16759000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentliabilities,dividendspayable,Dividends Payable,+,credit,usd,88000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10571000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,28189000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,82003000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,222000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,82225000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,110192000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,430135000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-417348000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,10000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,12797000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,12797000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,12797000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,,2012-09-30,2012-11-14 12:06:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,123211000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,28435000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,58252000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9798000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10167000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,106752000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7307000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,9095000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,34000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,528000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13262000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,,totalassets,Total Assets,=,debit,usd,127321000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6254000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,31184000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10645000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,231000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,48314000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,34076000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,75871000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,-73000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,111074000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,159461000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,438222000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-470269000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-20000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-32067000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-32067000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-32067000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,,2013-03-31,2013-05-13 12:26:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,127321000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,30943000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,31197000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14537000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9170000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,85947000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8155000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,9015000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,31000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,567000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13218000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,,totalassets,Total Assets,=,debit,usd,107320000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9970000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,36322000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9336000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2119000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,57747000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30592000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,68724000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7156000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,107672000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,165661000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,442257000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-500351000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-58099000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-58099000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-58099000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,,2013-06-30,2013-08-08 13:10:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,107320000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,105451000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,77034000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8835000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8860000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,200281000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,11468000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,8125000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,181000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,583000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12494000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,,totalassets,Total Assets,=,debit,usd,224243000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6376000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,42913000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9336000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2234000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,60859000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,104953000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,66390000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7102000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,179645000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,240878000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,523737000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-539982000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-16000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-16261000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-16261000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-16261000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,,2013-09-30,2013-11-08 13:55:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,224243000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,66897000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,57279000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12155000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2450000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,138882000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13779000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7965000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,167000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12321000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,,totalassets,Total Assets,=,debit,usd,164982000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,12022000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,34110000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10857000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,56989000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,101789000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,70800000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,168000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,173957000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,230778000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,533874000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-599830000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-8000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-65964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-65964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-65964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,,2014-03-31,2014-05-06 16:28:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,164982000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,77751000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,14995000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4396000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,103848000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13731000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7885000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,160000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12234000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,,totalassets,Total Assets,=,debit,usd,129813000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,11052000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,32208000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,47593000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,90853000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,105135000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9750000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,-13000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,116072000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,206938000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,540830000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-617939000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-77112000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-77112000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-77112000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,,2014-06-30,2014-08-11 16:02:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,129813000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,100323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,53356000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2568000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5795000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,162143000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14313000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7805000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,152000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12146000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,,totalassets,Total Assets,=,debit,usd,188602000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,15227000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,35989000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,70019000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,121235000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,103428000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,62603000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,167231000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,288466000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,546169000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-645840000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-43000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-99714000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-99714000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-150000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-99864000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,,2014-09-30,2014-11-10 17:11:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,188602000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,28833000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,62938000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4248000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3178000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,99298000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15749000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7645000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,139000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11973000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,,totalassets,Total Assets,=,debit,usd,127020000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,42979000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,60730000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,103709000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,122080000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,28853000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,152133000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,255842000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,560269000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-689460000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-27000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-129218000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-129218000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,396000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-128822000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,,2015-03-31,2015-05-07 17:01:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,127020000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33664000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,33991000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1762000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5366000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,74884000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18273000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7565000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,132000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11886000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,,totalassets,Total Assets,=,debit,usd,105043000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1058000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,46626000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,60928000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,108612000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,123117000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,15178000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,139495000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,248107000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,568862000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-712193000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-6000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-143337000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-143337000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,273000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-143064000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,,2015-06-30,2015-08-10 17:13:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,105043000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56350000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,6000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2051000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6419000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,70921000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,19964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7485000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,125000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11799000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,,totalassets,Total Assets,=,debit,usd,102684000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,38702000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,56560000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,95262000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,126261000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,20626000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,148087000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,243349000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,613261000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-754407000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-141146000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-141146000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,481000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-140665000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,,2015-09-30,2015-11-09 17:07:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,102684000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,48237000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,84153000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15637000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,8083000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4470000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,160681000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,20824000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7211000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11427000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,,totalassets,Total Assets,=,debit,usd,192932000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,50449000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,46914000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,97363000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,259843000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,52869000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,312712000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,410075000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,623522000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-840705000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-14000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-217197000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-217197000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,54000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-217143000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,,2016-03-31,2016-05-02 17:17:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,192932000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21491000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,61176000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,19325000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,12321000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4619000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,119033000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,19614000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7066000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,674000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11372000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,,totalassets,Total Assets,=,debit,usd,150019000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,44796000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,46092000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,90888000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,215544000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,45145000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,260689000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,351577000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,690050000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-891455000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-201404000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-201404000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-154000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-201558000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,,2016-06-30,2016-08-04 17:11:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,150019000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36463000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,102000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12003000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,22170000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,14770000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4109000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,89617000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17564000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,6922000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,674000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11228000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,,totalassets,Total Assets,=,debit,usd,118409000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,49699000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,88283000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,216871000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,40398000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,257269000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,345552000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,694743000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-921523000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-226782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-226782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-361000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-227143000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,,2016-09-30,2016-11-09 17:20:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,118409000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17155000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,102000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,43000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2338000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcurrentassets,othercurrentnonoperatingassets,Other Current Nonoperating Assets,+,debit,usd,26634000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,46272000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,12852000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,9488000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9515000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,,totalassets,Total Assets,=,debit,usd,68639000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,38756000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2054000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,67187000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,107997000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,218041000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2868000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,16877000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,237786000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,345783000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,708747000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-984485000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-275738000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-275738000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-1406000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-277144000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,,2017-03-31,2017-05-10 16:53:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,68639000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,135501000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,102000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,43000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5917000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,141563000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,11178000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,60709000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,60709000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,,totalassets,Total Assets,=,debit,usd,213450000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,33989000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2077000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,8141000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,13530000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,57737000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,48906000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2330000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51236000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,108973000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,579430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-472922000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,106508000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,106508000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-2031000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,104477000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,,2017-06-30,2017-08-09 16:29:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,213450000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,107245000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,102000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,190000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8040000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,115577000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,10188000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,11400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,60682000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,72082000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,,totalassets,Total Assets,=,debit,usd,197847000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,23983000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2117000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1844000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,6613000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34557000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,49884000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1772000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51656000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,86213000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,581454000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-469820000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,111634000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,111634000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,111634000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,,2017-09-30,2017-11-08 11:49:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,197847000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34268000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,41998000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,844000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,77110000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5358000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,9805000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4548000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,674000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,15027000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,,totalassets,Total Assets,=,debit,usd,97495000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2211000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17534000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,651000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,56000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,707000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18241000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,579819000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-500553000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-12000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,79254000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,79254000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,79254000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,,2018-03-31,2018-05-08 10:40:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,97495000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,22460000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,37544000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1727000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,61731000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4143000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,9134000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4634000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14352000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,,totalassets,Total Assets,=,debit,usd,80226000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15569000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2325000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17894000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,56000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,56000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17950000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,580599000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-518322000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,62276000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,62276000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,62276000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,,2018-06-30,2018-08-07 08:01:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,80226000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,49794000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,35052000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1837000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,87267000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3188000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,8893000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4568000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13461000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,,totalassets,Total Assets,=,debit,usd,103916000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,19049000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1676000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,1340000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22065000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,14752000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,56000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,14808000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,36873000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,581381000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-514333000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,67043000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,67043000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,67043000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,,2018-09-30,2018-11-07 09:01:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,103916000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36542000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,21924000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4644000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,63694000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1009000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,7127000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2523000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9650000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,,totalassets,Total Assets,=,debit,usd,74353000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1475000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10339000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11814000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,13519000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,56000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,13575000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25389000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,582699000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-533735000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,48964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,48964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,48964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,,2019-03-31,2019-05-10 08:31:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,74353000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36917000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,584000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,2987000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2069000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,42557000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2483000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2483000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,,totalassets,Total Assets,=,debit,usd,45040000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4940000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4940000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,56000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,56000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,4996000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,583209000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-543165000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,40044000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,40044000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,40044000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,,2019-06-30,2019-07-17 07:01:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,45040000.0
